Literature DB >> 26496997

[Hepatocellular tumours in noncirrhotic liver tissue].

D Goltz, H-P Fischer.   

Abstract

In recent years, the spectrum of tissue-based diagnostics of hepatocellular tumours has changed due to novel molecular pathological findings. Innovative radiographics filter out small lesions and ambiguous tumours for bioptical sampling. The spectrum of these tumours includes hepatocellular carcinoma, hepatocellular adenomas, focal nodular hyperplasia and macroregenerative nodules. Primarily, morphological analysis should identify the dignity of a lesion. After exclusion of HCC and reactive liver cell nodules, hepatocellular adenomas should be further subclassified based on immunohistochemical/molecular pathological criteria according to the WHO classification of liver tumours. This procedure provides significant additional information regarding the prognosis and therapeutic implications of hepatocellular adenomas.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26496997     DOI: 10.1007/s00292-015-0113-0

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  33 in total

1.  GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.

Authors:  Jean Charles Nault; Monique Fabre; Gabrielle Couchy; Camilla Pilati; Emmanuelle Jeannot; Jeanne Tran Van Nhieu; Marie-Christine Saint-Paul; Anne De Muret; Marie-José Redon; Catherine Buffet; Sylvie Salenave; Charles Balabaud; Sophie Prevot; Philippe Labrune; Paulette Bioulac-Sage; Jean-Yves Scoazec; Philippe Chanson; Jessica Zucman-Rossi
Journal:  J Hepatol       Date:  2011-08-09       Impact factor: 25.083

2.  Glutamine synthetase interpretation in hepatocellular adenoma.

Authors:  Charles Balabaud; Paulette Bioulac-Sage
Journal:  Virchows Arch       Date:  2014-09-13       Impact factor: 4.064

3.  Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC.

Authors:  K Kenmochi; S Sugihara; M Kojiro
Journal:  Liver       Date:  1987-02

4.  P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.

Authors:  Ya-Wen Chen; Yung-Ming Jeng; Shiou-Hwei Yeh; Pei-Jer Chen
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

5.  Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.

Authors:  Masafumi Inoue; Yoshihisa Takahashi; Takeshi Fujii; Masanobu Kitagawa; Toshio Fukusato
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

6.  Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.

Authors:  Nafis Shafizadeh; Gillian Genrich; Linda Ferrell; Sanjay Kakar
Journal:  Hum Pathol       Date:  2014-01-08       Impact factor: 3.466

7.  Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Gabrielle Couchy; Brigitte Le Bail; Antonio Sa Cunha; Anne Rullier; Christophe Laurent; Jean-Frédéric Blanc; Gaelle Cubel; Hervé Trillaud; Jessica Zucman-Rossi; Charles Balabaud; Jean Saric
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

Review 8.  [Hepatocellular carcinoma in the non-cirrhotic liver].

Authors:  M Evert; F Dombrowski
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

9.  Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas.

Authors:  Camilla Pilati; Mohamed Amessou; Michel P Bihl; Charles Balabaud; Jeanne Tran Van Nhieu; Valérie Paradis; Jean Charles Nault; Tina Izard; Paulette Bioulac-Sage; Gabrielle Couchy; Karine Poussin; Jessica Zucman-Rossi
Journal:  J Exp Med       Date:  2011-06-20       Impact factor: 14.307

10.  Histological and immunohistochemical revision of hepatocellular adenomas: a learning experience.

Authors:  S Fonseca; D Hoton; S Dardenne; L Annet; C Hubert; S Godecharles; A Jouret-Mourin; R Reding; J B Otte; J Rahier; J F Gigot; C Sempoux
Journal:  Int J Hepatol       Date:  2013-02-28
View more
  1 in total

1.  [Hepatocellular carcinomas and their mimics].

Authors:  H-P Fischer; D Goltz
Journal:  Pathologe       Date:  2019-02       Impact factor: 1.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.